Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$167,291,584
+$44,015,543 QoQ
Shares Held
774,283
+15.1% QoQ
Ownership
0.524%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#31
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. BIIB ranks #12 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $167,291,584 | 774,283 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $123,276,041 | 672,427 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $139,396,574 | 792,071 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $135,241,215 | 965,457 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $104,732,891 | 833,927 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $157,529,113 | 1,151,192 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $295,703,850 | 1,933,716 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $370,727,916 | 1,912,546 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $466,285,297 | 2,011,411 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $342,771,700 | 1,589,629 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $390,314,693 | 1,508,346 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $299,038,845 | 1,163,530 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $321,493,673 | 1,128,642 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $580,625,617 | 2,088,356 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $386,722,379 | 1,396,513 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $409,715,505 | 1,534,515 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $210,248,068 | 1,030,931 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $226,599,071 | 1,075,969 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $271,435,171 | 1,131,357 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $504,892,646 | 1,784,136 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $558,382,190 | 1,612,563 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $497,163,587 | 1,777,171 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $413,151,788 | 1,687,298 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $389,004,994 | 1,371,281 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $323,167,758 | 1,207,878 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,355,548,143 | 4,284,557 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||